Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania

doi:10.1084/jem.169.5.1819

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Hill, J. O.
	Articles by North, R. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Hill, J. O.
	Articles by North, R. J.


Social Bookmarking

	What's this?

ARTICLES

Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania

JO Hill, M Awwad and RJ North
Trudeau Institute, Saranac Lake, New York 12983.

This study examined the capacity of BALB/c mice that had been depleted of T cell subpopulations to generate a protective immune response to Leishmania major. Thymectomized mice were depleted of either L3T4+ (CD4+) T lymphocytes, Ly2+ (CD8+) T lymphocytes, or both, by treatment with appropriate mAbs. It was found that susceptible mice were rendered resistant to Leishmania by an intravenous infusion of anti-L3T4 mAb. These mice generated an immune response that destroyed the parasite in the primary lesion and in visceral metastatic foci. CD4+ cell-depleted mice also acquired a capacity to mount a sustained delayed-type hypersensitivity (DTH) response to parasite antigens, indicating that DTH, per se, is not a disease-promoting mechanism in the susceptible murine host as has been suggested. Depleting BALB/c mice of CD8+, as well as CD4+ T cells, left them highly susceptible to Leishmania infection, thereby indicating that CD8+ lymphocytes are key protective cells. Our results can be interpreted as showing that the susceptibility of BALB/c mice is due to the generation of CD4+ cells that suppress either the generation or expression of CD8+ T cell- mediated antiLeishmania immunity.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Bomfim, G., Andrade, B. B., Santos, S., Clarencio, J., Barral-Netto, M., Barral, A. (2007). Cellular Analysis of Cutaneous Leishmaniasis Lymphadenopathy: Insights into the Early Phases of Human Disease. Am J Trop Med Hyg 77: 854-859 [Abstract] [Full Text]
Acres, B., Gantzer, M., Remy, C., Futin, N., Accart, N., Chaloin, O., Hoebeke, J., Balloul, J.-M., Paul, S. (2005). Fusokine Interleukin-2/Interleukin-18, a Novel Potent Innate and Adaptive Immune Stimulator with Decreased Toxicity. Cancer Res. 65: 9536-9546 [Abstract] [Full Text]
Li, J., Hu, P., Khawli, L. A., Epstein, A. L. (2003). Complete Regression of Experimental Solid Tumors by Combination LEC/chTNT-3 Immunotherapy and CD25+ T-Cell Depletion. Cancer Res. 63: 8384-8392 [Abstract] [Full Text]
Colmenares, M., Kima, P. E., Samoff, E., Soong, L., McMahon-Pratt, D. (2003). Perforin and Gamma Interferon Are Critical CD8+ T-Cell-Mediated Responses in Vaccine-Induced Immunity against Leishmania amazonensis Infection. Infect. Immun. 71: 3172-3182 [Abstract] [Full Text]
Pompeu, M. M. L., Brodskyn, C., Teixeira, M. J., Clarencio, J., Van Weyenberg, J., Coelho, I. C. B., Cardoso, S. A., Barral, A., Barral-Netto, M. (2001). Differences in Gamma Interferon Production In Vitro Predict the Pace of the In Vivo Response to Leishmania amazonensis in Healthy Volunteers. Infect. Immun. 69: 7453-7460 [Abstract] [Full Text]
Gurunathan, S., Stobie, L., Prussin, C., Sacks, D. L., Glaichenhaus, N., Fowell, D. J., Locksley, R. M., Chang, J. T., Wu, C.-Y., Seder, R. A. (2000). Requirements for the Maintenance of Th1 Immunity In Vivo Following DNA Vaccination: A Potential Immunoregulatory Role for CD8+ T Cells. J. Immunol. 165: 915-924 [Abstract] [Full Text]
Huber, M., Timms, E., Mak, T. W., Rollinghoff, M., Lohoff, M. (1998). Effective and Long-Lasting Immunity against the Parasite Leishmania major in CD8-Deficient Mice. Infect. Immun. 66: 3968-3970 [Abstract] [Full Text]
Gurunathan, S., Sacks, D. L., Brown, D. R., Reiner, S. L., Charest, H., Glaichenhaus, N., Seder, R. A. (1997). Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major. J. Exp. Med. 186: 1137-1147 [Abstract] [Full Text]
Lang, T, de Chastellier, C, Frehel, C, Hellio, R, Metezeau, P, Leao, S., Antoine, J. (1994). Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis. J. Cell Sci. 107: 69-82 [Abstract]
Salgame, P, Abrams, J., Clayberger, C, Goldstein, H, Convit, J, Modlin, R., Bloom, B. (1991). Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254: 279-282 [Abstract]